The animal healthcare industry involves various veterinary services, therapeutics, vaccines, feed additives, and other disease prevention products for livestock and companion animals. Animal healthcare products ensure the overall well-being of animals. They treat injury, diseases, and improve animal performance. With rising pet ownership and growing population of livestock animals, demand for animal healthcare services and products is increasing. The global animal healthcare industry aims to provide various preventive healthcare solutions and tackle diseases affecting animals worldwide. The global Animal Healthcare Market is estimated to be valued at US$ 50.45 Bn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key drivers for the animal healthcare market is rising awareness about animal health and wellbeing among pet owners and livestock farmers. As animals are being recognized more as companions than before, their healthcare is now regarded as equally important as human healthcare. This has propelled the demand for various vaccines, pharmaceuticals, and diagnostic tools to prevent disease outbreaks in animals. Additionally, growing livestock industry in developing nations has amplified the need for superior animal care amid risks of zoonotic diseases. Various initiatives by governments and animal welfare organizations to curb infections in animals will further support the animal healthcare market growth over the forecast period. SWOT Analysis Strength: The animal healthcare market has large potential for growth given increasing pet adoption and livestock population. Vaccines and pharmaceuticals have demonstrated efficacy in disease prevention and treatment, helping ensure animal health and welfare. Manufacturers continue developing new drugs and therapies to address emerging diseases. Weakness: Significant R&D investments are required to develop innovative drugs and therapies, placing cost pressure on companies. Generic competition can erode profits of patented drugs after expiration. Farmers in developing regions may lack access to advanced animal care products due to cost constraints. Opportunity: Rising pet ownership in developing nations boosts demand for preventive healthcare and nutrition. Livestock population growth in Asia and Africa opens potential markets. Technologies like biosensors, imaging, and big data can enhance disease detection and treatment monitoring. Threats: Strict regulations govern product approval process, while compliance requirements raise costs. Supply chain disruptions and outbreaks of diseases like African swine fever challenge smooth operations. Economic slowdowns may curb consumer spending on animal care. Key Takeaways The global Animal Healthcare Market Growth is expected to witness high growth on account of increasing pet adoption as well as expansion of the global livestock population. Regional analysis The Asia Pacific region is expected to grow at the fastest CAGR in the global animal healthcare market during 2023-2030. This can be attributed to rapidly growing livestock population in major Asian countries such as China and India which are major beef and pork producers worldwide. Furthermore, increasing pet adoption and rising awareness about pet healthcare is augmenting the demand for animal medicines, vaccines, and nutrition products in Asia Pacific. Key players Key players operating in the animal healthcare market include Low & Bonar PLC, Ahlstrom Group, E. I. du Pont de Nemours and Company, 3M Company, Polymer Group Inc., Milliken & Company Inc., Arville Textiles Ltd., Dickson-Constant, Baltex, and Freudenberg & Co. KG. These companies have strong global presence and offer broad portfolios of pharmaceuticals, vaccines, and other animal care products. They are focusing on expanding in high growth emerging markets through new product launches and acquisition strategies. For more insights, read- https://www.pressreleasebulletin.com/animal-healthcare-market-trends-size-and-share-analysis
0 Comments
Aluminum extrusion is a process that uses aluminum alloy to produce items of a fixed cross-sectional profile. Aluminum extrusions are used in various applications including doors, window frames, curtains and sunroofs in automobiles. The increasing construction of commercial and residential buildings has fueled the adoption of aluminum extrusion applications such as window and door frames and curtain walls. The global aluminum extrusion market is estimated to be valued at US$ 110 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: The global aluminum extrusion market is driven by the increasing demand from the construction industry. The rising construction of commercial buildings and residential homes has fueled the adoption of aluminum extrusion profile products such as window and door frames, curtain walls, and sunroofs for vehicles. This rapid growth in the real estate and construction sectors, especially in emerging nations such as China, India and various Southeast Asian countries has boosted the aluminum extrusion market growth. Moreover, aluminum extrusion is a material that offers other benefits such as lightweight, corrosion resistance, and recyclability which further increases its preference over other materials. This has resulted in aluminum extrusion demand increasing from sectors such as transportation and machinery manufacturing. SWOT Analysis Strength: Aluminum is a lightweight material that is corrosion-resistant and durable. These properties make aluminum extrusions suitable for construction, transportation, and packaging applications. Aluminum extrusions also have good thermal conductivity allowing efficient heat transfer. Extruded aluminum parts have precision shapes that can be customized as per industry or customer requirements. Weakness: The aluminum extrusion process requires high capital investment in specialized hydraulic presses and tooling. Fluctuations in aluminum prices can impact the profit margins for aluminum extrusion manufacturers. Further, rising energy costs needed for powering hydraulic presses negatively impacts production costs. Opportunity: Growth of end-use industries such as construction, automotive, and packaging provides opportunities for increased demand of aluminum extrusions. The construction industry across developing nations in Asia and Africa is expanding rapidly creating a steady requirement for aluminum alloy building parts. Further, shift towards green energy applications increases the scope for use of aluminum in solar panels and electric vehicles. Threats: Stagnating global economic conditions may negatively impact the sales and profitability of aluminum extrusion companies. Imposition of import tariffs on aluminum extrusions trade between countries can disrupt established supply chains. Considering aluminum is primarily sourced from China, geopolitical tensions causes price and supply instability. Substitution threat exists from competitive lightweight materials especially in automotive and packaging industries. Key Takeaways The global Aluminum Extrusion Market Growth is expected to witness high growth over the forecast period supported by robust gains in key end-use industries and replacement of traditional materials. Regional Analysis: The Asia Pacific region currently dominates the global market share led by China, Japan, and India. Expanding construction and infrastructure development projects across developing Asian countries will accelerate the regional growth of aluminum extrusions demand exceeding 50% of global consumption by 2030. Key players in the aluminum extrusion market are focusing on capacity expansions and mergers and acquisitions for gaining market share and access to new production facilities. For instance, global leader PPD Inc. acquiredIcon Plc in 2018 to strengthen its clinical research expertise across various therapeutic areas. Similarly, Syneos Health merged with Laboratory Corporation of America Holdings to offer integrated full-service solutions along the drug development value chain. Collaboration between Charles River Laboratories International Inc. and other players is likely to improve service capabilities. For more insights, read- https://www.pressreleasebulletin.com/aluminum-extrusion-market-trends-size-and-share-analysis An air data indicator is an aircraft instrumentation system that senses, calculates and displays aircraft airspeed, altitude and other flight data parameters derived from measurements of aircraft flight air data. It is a critical component of the instruments used for both commercial and general aviation. Modern air data indicators provide more features than traditional systems, such as graphing airspeed and altitude over time, barometric pressure displays, and digital data interfaces. The global air data indicator market is estimated to be valued at US$ 1.65 Bn or Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics: The growth of the global air data indicator market is primarily driven by the modernization of aging aircraft fleet across various countries. According to the United Nations World Tourism Organization, international tourist arrivals reached 1.5 billion globally in 2022, indicating significant growth opportunities for both commercial and general aviation. This has prompted airline operators and aircraft manufacturers to replace aging fleets with more modern and fuel-efficient aircraft models integrated with advanced avionics systems that require state-of-the-art air data indicators. Additionally, increasing air passenger traffic is expected to spur the demand for new aircraft deliveries over the forecast period. For instance, Boeing projects the need for over 42,000 new commercial aircraft valued at $7.2 trillion between 2023 and 2042. However, the high costs associated with aircraft instrumentation systems slightly hinder the market growth. SWOT Analysis Strength: The air data indicator market has seen strong growth in the aviation industry over the past few years. Advances in sensor technologies have improved accuracy and reliability. Manufacturers are also developing more compact and affordable systems. Weakness: Maintenance and calibration of air data indicators can be complex and expensive. Failure of these critical systems during flight poses safety risks. Adverse weather also impacts sensor performance. Opportunity: Development of next-generation aircraft concepts will drive demand for advanced air data sensing solutions. Integration of multiple parameters into intelligent systems presents new opportunities. Emerging economies are expanding their aviation sectors. Threats: Economic slowdowns can negatively impact aircraft procurement cycles and aftermarket services. Strict regulatory standards increase certification costs. Alternative technologies may disrupt traditional sensor designs. Key Takeaways The global Air Data Indicator Market Growth is expected to witness high growth over the forecast period of 2023 to 2030. The market size is projected to reach US$ 1.65 billion by 2023, growing at a CAGR of 4.9% through 2030. Regional analysis shows that North America currently dominates the market due to strong aviation demand. However, Asia Pacific is poised to become the fastest growing regional market. Key players operating in the air data indicator market include Mohawk Industries, IVC Group, Shaw Industries Group, Inc., Armstrong Flooring, Inc., Mannington Mills, Inc., Beaulieu International Group, NOX Corporation, Forbo Holding AG, Interface, Inc. Mohawk Industries is the global leader with a wide portfolio of air data sensors. IVC Group is its main subsidiary focused on the aviation aftermarket. For more insights, read- https://www.pressreleasebulletin.com/air-data-indicator-market-trends-size-and-share-analysis/ Weather radar is an essential tool for meteorologists that uses pulsed radio waves to locate precipitation and wind in the Earth's atmosphere. It detects the size, location, and motion of objects such as raindrops, snowflakes, and hail. Weather radars are also used by the military, aviation sector, and broadcast meteorologists to scan the skies and warn populations of approaching severe weather. They provide vital information to predict weather patterns, track storms, and monitor atmospheric conditions.
The global weather radar market is estimated to be valued at US$ 136.28 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: As mentioned in the heading, the weather radar market is witnessing high growth owing to the increasing demand for precision in weather forecasting. Weather forecasting plays a crucial role in various industries such as aviation, maritime, agriculture, and energy. Thus, demand for accurate weather predictions is driving the need for advanced weather radars with higher resolution. Furthermore, weather radars with dual polarization technology provide more comprehensive data about the storm's composition and structure which helps meteorologists in better analysis and warnings. This is expected to fuel the growth of the weather radar market over the forecast period. SWOT Analysis Strength: Weather Radar Market technology is evolving rapidly with advanced features like dual polarization, phased array, and digital signal processing enabling more accurate predictions. Weather radars can scan the atmosphere quickly to detect storms, winds, rainfall intensity which helps issue timely warnings. They provide high-resolution images and data on precipitation types over large areas. Weakness: High installation and maintenance costs of weather radars pose budgetary challenges for weather services. Accuracy may reduce at long ranges due to beam broadening and attenuation effects. Certain weather phenomena like hail are still difficult to detect precisely. Opportunity: Growing demand for hyperlocal weather forecasts is opening opportunities to deploy more compact, low-cost weather radars. Integrating weather radars with AI/ML models can improve nowcasting abilities. Increasing awareness on climate change is propelling investments in modernizing national weather radar networks. Threats: Technological advancements by competitors may lead to faster obsolescence of existing radars. Budget cuts during economic downturns may delay radar procurements and upgrades. Natural calamities can damage expensive radar infrastructure requiring costly repairs. Key Takeaways The global Weather Radar Market is expected to witness high growth. The global weather radar market is estimated to be valued at US$ 136.28 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030. Regional analysis related content comprises North America currently dominates the market due to large investments in updating NEXRAD network of Doppler weather radars along coastal regions. Asia Pacific is poised to grow at fastest pace on account of radar deployment plans across China, India and Southeast Asian countries to strengthen disaster management. Key players related content comprises Key players operating in the Weather Radar Market are Diageo PLC, Bacardi Ltd, Asahi Group Holdings Ltd, Pernod Ricard SA, and Suntory Beverage & Food Ltd, among others. These companies are focusing on improving spectral diversity, beamforming techniques and decentralizing radar networks. They have been partnering with meteorological departments and disaster management agencies for product development and supply contracts. For more insights, read- https://www.pressreleasebulletin.com/weather-radar-market-trends-size-and-share-analysis/ Scopolamine is an alkaloid drug derived from plants belonging to the family Solanaceae, which provides relief from motion sickness. It works by blocking signals in the brain that cause nausea and vomiting. Scopolamine is used to treat and prevent motion sickness, postoperative nausea and vomiting, nausea associated with cancer chemotherapy and gastroenteritis.
The global scopolamine API market is estimated to be valued at US$ 308.49 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: Growth in the global scopolamine API market is majorly driven by increasing applications of scopolamine API in treatment of motion sickness as well as nausea and vomiting associated with cancer chemotherapy and postoperative nausea and vomiting. Scopolamine is considered as the gold standard drug for prevention of motion sickness owing to its strong antiemetic effects and longer duration of action. According to various published studies, scopolamine patches are more than 80% effective in preventing motion sickness. Scopolamine patches and gums have become popular OTC medication for motion sickness. Thus, increasing incidence of motion sickness during travel via road, rail or sea is expected to drive the demand for scopolamine API over the forecast period. SWOT Analysis Strength: The Scopolamine API market is expected to grow at a CAGR of 10% during the forecast period. Scopolamine is used to treat motion sickness and post-operative nausea. The increasing demand for pharmaceutical products is driving market growth. The rising prevalence of cancer and neurological disorders is fuelling demand for scopolamine-based drugs. Weakness: Stringent regulations associated with API manufacturing may hamper market growth. High costs associated with R&D activities can negatively impact small players. Opportunity: Growing geriatric population suffering from neurological disorders creates lucrative opportunities. Increasing healthcare expenditure in emerging nations provides potential opportunities. Threats: Availability of alternative therapies and substitutes poses a threat. Rising environmental concerns associated with API production threats market growth. Key Takeaways The global Scopolamine API Market Growth is expected to witness high growth. The global scopolamine API Market is estimated to be valued at US$ 308.49 Mn in 2023 and is expected to exhibit a CAGR of 10 % over the forecast period 2023 to 2030. North America is currently the largest market for scopolamine API due to rising prevalence of motion sickness and cancer. The dominant market share can be attributed to growing healthcare expenditure, availability of advanced healthcare facilities, and presence of prominent market players in the region. Asia Pacific is expected to be the fastest-growing regional market owing to rising geriatric population, growing healthcare spending, and increasing prevalence of cancer and neurological disorders. Moreover, increasing investments by global market players are driving market growth in Asia Pacific region. Key players operating in the scopolamine API market include Daikin Industries Limited, Viessmann Group, NIBE Group, Danfoss Group Global, Stiebel Eltron Group, Mitsubishi Electric Corporation, United Technologies Corporation, Panasonic Corporation, Glen Dimplex Group, The Bosch Group. The market is dominated by global players accounting for more than 50% of the total market share. Strategic collaborations, mergers, acquisitions, new product launches, and regional expansion are common strategies adopted by these companies to gain higher market shares and strengthen their product portfolio. For more insights, read- https://www.pressreleasebulletin.com/scopolamine-api-market-trends-size-and-share-analysis/ The global roofing systems market is experiencing high demand owing to rapid urbanization and infrastructure development activities across both developed and emerging nations. A roofing system refers to the covering of a building structure's uppermost section and its purpose is to weatherproof the building from rain, snow, wind, sunshine, and fire. Some of the common roof materials include asphalt shingles, clay tiles, concrete tiles, metal roofing, thermoplastic polyolefin (TPO) membranes, and ethylene propylene diene monomer (EPDM) rubber roofing. The global roofing systems market is estimated to be valued at US$ 133.67 Bn in 2023 and is expected to exhibit a CAGR of 6.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics: The rapid rate of urbanization across developing regions is the key driver propelling the growth of roofing systems market. According to the United Nations, currently 55% of the world's population lives in urban areas and is expected to increase to 68% by 2050. The massive housing demand from growing urban populations has led to increase in residential construction activities worldwide. Further, large-scale infrastructure projects such as roads, airports, railways, stadiums etc require extensive roofing, thus supplementing the market growth. However, fluctuating raw material prices remains a challenge for roofing systems manufacturers and their margins. The volatility in prices of bitumen, polyvinyl chloride (PVC), and fluoropolymers can adversely impact the production cost of roofing membranes and sheets. nevertheless, development of bio-based roofing materials using agricultural waste provide new opportunities for players in this market. SWOT Analysis Strength: Roofing systems provide weatherproofing and protection for buildings. Several material options allow for flexibility in meeting different design and performance requirements. Installation of roofing systems involves trained professionals, ensuring quality workmanship. Weakness: More expensive roofing materials can increase upfront construction costs. Complex roofs with many components require greater expertise during installation. Improper installation can compromise the weatherproofing function over time. Opportunity: Growth in new construction projects to meet rising housing needs boosts demand for roofing systems. Replacement and retrofitting of aging roofs in existing buildings also creates opportunities. Increasing concerns about energy efficiency can support demand for roofing materials with insulating properties. Threats: Availability and price volatility of raw materials used in roofing systems poses risks. Stricter building codes increase performance standards that some existing solutions may not meet. Changes in weather patterns may impact design requirements in some regions. Key Takeaways The global Roofing Systems Market Growth is expected to witness high growth over the forecast period of 2023 to 2030. The residential construction segment accounts for the largest share currently. Regional analysis The Asia Pacific region dominated the global roofing systems market in 2023 with largest market share of over 35%, and this trend is expected to continue during the forecast period as well. China, India, Japan and other Southeast Asian countries are rapidly urbanizing with massive infrastructure development programs. This coupled with initiatives to enhance building energy efficiency is propelling demand for roofing systems in the residential, commercial and industrial construction segments. Governments are also supporting use of sustainable materials through policy measures, favoring market growth. However, North America and Europe are anticipated to exhibit steady growth owing to focus on roof repairs and renovation projects in existing buildings. Key players Key players operating in the roofing systems market are focusing on capacity expansions, new product launches and mergers & acquisitions to strengthen their market position. Waifair LLC commands a major share through its wide distribution network across the United States. Westminster Teak Inc. For more insights, read- https://www.pressreleasebulletin.com/roofing-systems-market-trends-size-and-share-analysis/ Respiratory inhalers are medical devices used for the treatment of respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). Dry powder inhalers (DPI) and metered dose inhalers (MDI) are the most common types of respiratory inhalers. DPIs contain medication in powder form and require the patient to inhale forcefully. MDIs contain medication in pressurized liquid form and require coordination of actuation and inhalation. Inhalers help deliver medication directly to the respiratory tract for quicker symptomatic relief. They have minimal systemic effects and are generally well-tolerated. The global respiratory inhalers market is estimated to be valued at US$ 29.55 Bn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics: The rising prevalence of respiratory diseases like asthma and COPD is expected to drive the growth of the respiratory inhalers market. According to WHO, asthma currently affects an estimated 262 million people worldwide. It is a common long-term condition that can cause wheezing, breathlessness, chest tightness and coughing. Inhalers provide quick relief during asthma attacks and are thus widely used. Similarly, COPD prevalence is increasing due to rising pollution levels and cigarette smoking. It was responsible for over 3 million deaths globally in 2019 according to WHO. Inhalers such as bronchodilators are mainly used for symptom relief in COPD. Newer smart inhalers with sensors are also gaining traction as they can track medication use and provide feedback to patients and doctors. These factors coupled with growing awareness about respiratory diseases are expected to boost the respiratory inhalers market during the forecast period. SWOT Analysis Strength: Respiratory inhalers offer quick relief from asthma and COPD symptoms. They are portable and provide relief instantly in emergency situations. Moreover, advanced digital inhalers provide real-time monitoring and feedback which help patients manage their conditions better. Weakness: Reliance on frequent refills can be costly for patients over the long run. Some patients also find it difficult to use inhalers properly. Certain inhalers also require regular maintenance like cleaning. Opportunity: Growing awareness about respiratory diseases and their management presents an opportunity for inhaler manufacturers. Increasing healthcare expenditure in developing nations also expands the customer base. Moreover, development of combinational inhalers targeting multiple conditions can boost the market. Threats: Alternative delivery methods like oral medications and nebulizers provide competition. Stringent regulations on new product approval delays market entry. Supply chain and production disruptions from events like COVID-19 pandemic can also adversely impact the industry. Key Takeaways The global Respiratory Inhalers Market Share is expected to witness high growth over the forecast period. Rising cases of asthma and COPD due to environmental pollution and changing lifestyle habits is driving the need for effective therapeutic solutions. North America currently dominates the market due to high healthcare expenditures and advanced healthcare facilities in the region. However, Asia Pacific is expected to emerge as the fastest-growing market due to growing patient population, increasing awareness, and improving access to healthcare. Regional analysis Asia Pacific region is projected to witness the highest growth during the forecast period owing to the large patient base, healthcare infrastructure development, and rising disposable incomes. Countries like China, India, and Japan are major contributors to the regional market. Availability of generic drugs and medical devices at affordable prices also makes respiratory therapy accessible to a wider population. Key players Key players operating in the respiratory inhalers market include Unilever, Procter & Gamble, Reckitt Benckiser, Henkel AG & Co. KGaA, Church & Dwight Co. Inc., Wipro Enterprises Limited, Colgate-Palmolive Company, C.Johnson & Son Inc., Godrej Consumer Products, Kao Corporation, L'Oreal S.A., The Clorox Company, Seventh Generation, Inc., Natura &Co, Weleda Group, Patanjali Ayurved Limited, Hain Celestial, EO Products, Indus Valley, Prairie Rose. For more insights, read- https://www.pressreleasebulletin.com/respiratory-inhalers-market-trends-size-and-share-analysis/ The rescue pole, also known as a safety pole, is a long pole, often made of fiberglass, that is used as a safety device for ice fishermen and others working on frozen bodies of water such as lakes or rivers. Rescue poles allow fishermen and others walking on the ice to pull themselves back to safety if the ice breaks under their feet and they begin to fall through. They work by allowing the fisherman or other person to quickly position the pole on stable ice behind them when they feel the ice cracking, and then grasp or clip onto the pole to help pull themselves to safety. The rescue pole easily glides across the ice surface, which allows for efficient self-rescue. The global rescue pole market is estimated to be valued at US$ 12.64 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics: One of the key drivers for the rescue pole market is the rising inclination towards safety, especially while undertaking activities such as ice fishing, which presents the risk of falling through thin ice. Rescue poles provide an efficient self-rescue option to quickly pull oneself back to stable ice. Furthermore, with climate change leading to uncertain winters and unpredictable ice conditions in various regions, more fishermen and others are opting for rescue poles or ice awls as essential safety gear. Additionally, increased marketing and promotion of using rescue poles as a best practice for safety by ice fishing equipment manufacturers and winter sports associations is also fueling growth of the market. SWOT Analysis Strength: Rescue pole has enhanced safety features which helps in rescuing people during emergencies or accidents. The poles are long and sturdy which enables rescuing from heights and difficult terrains. It has a strong hook at the end which helps in securely catching and pulling the person in distress. Weakness: Rescue poles are heavy and bulky to carry around. Their handling and maneuvering requires special training. During severe weather conditions like strong winds, their effectiveness can reduce. Opportunity: With rising accidents and emergency cases globally, the need for advanced rescue equipment is increasing. There is scope to integrate additional safety features in rescue poles like lights, first aid kits to enhance their functionality. Developing lightweight yet durable materials can help address current limitations. Threats: Presence of alternative rescue equipment like ropes, harnesses poses competition. Economic slowdowns can impact safety budgets and discourage procurement of such specialized equipment. Stringent regulations pertaining to import of raw materials can raise production costs. Key Takeaways The global Rescue Pole Market Growth is expected to witness high growth over the forecast period of 2023 to 2030. Currently valued at US$ 12.64 billion in 2023, the market is projected to reach US$ 27.92 billion by 2030, reflecting a CAGR of 10%. Regional analysis comprises: North America dominates the rescue pole market currently due to stringent workplace safety standards and protocols in industrial sectors. Europe follows next on account rapid infrastructure development projects requiring safety of construction workers. The Asia Pacific region is expected to witness fastest growth in demand for rescue poles with increasing construction activities and industrialization. Countries like China and India will be key markets. Key players operating in the Rescue Pole market are Trimble, Topcon, Raven Industries, KUBOTA, Teletrac Navman, AGCO, Aagland, Lely, AgJunction, Robert Bosch, AgLeader Technology, AgEagle, DICKEY John, CLAAS, CNH Industrial, BouMatic, Hexagon Agriculture and Farmers Edge. These companies are focusing on development of innovative and lightweight pole designs integrated with advanced monitoring systems for enhanced safety and functionality. Partnerships with e-commerce channels will help strengthen distribution networks. For more insights, read- https://www.pressreleasebulletin.com/rescue-pole-market-trends-size-and-share-analysis Red biotechnology uses biologics and other methods to treat or prevent disease and improve human health through techniques like DNA manipulation and targeted drug delivery. It involves the application of biotechnology in medical therapy like pharmaceutical drugs, vaccines, gene therapy and monoclonal antibodies. Therapeutics areas of red biotechnology include hematology, oncology, cardiovascular, neurology, infectious diseases, and many more. The global Red Biotechnology Market is estimated to be valued at US$742.8 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics: Rising demand for healthcare needs is one of the key drivers expected to boost growth of the red biotechnology market over the forecast period. Growing prevalence of chronic diseases like cancer, diabetes, cardiovascular disorders etc. has generated increased requirement for development of novel drugs and therapeutics for efficient disease management. According to World Health Organization (WHO), chronic diseases accounted for approximately 60% of the total reported deaths in the world in 2020. Furthermore, growing geriatric population who are more prone to developing chronic health conditions will also foster market value of red biotechnology. As per United Nations report, worldwide share of population aged over 60 years will nearly double from 12% to 22% between 2015 and 2050. Apart from this, ongoing research and development activities to develop advanced targeted therapies will continue driving growth of red biotechnology market. SWOT Analysis Strength: Red biotechnology market has strong potential for growth due to rising demand for biologics and biosimilars. Government support for R&D in red biotechnology sectors will drive innovation. Significant investments made by key players for development of novel therapies will expand product pipeline. Weakness: High costs associated with R&D, clinical trials and production of biologics limits market access. Stringent regulations for approvals delay market entry of new products. Requirement of specialized infrastructure and skilled workforce increases operational expenses. Opportunity: Increasing prevalence of chronic diseases worldwide generates need for therapeutic molecules. Approvals for late stage pipeline drugs will open new revenue streams. Emerging economies offer lower production costs and present growth avenues. Collaborations between industry and academia can boost research. Threats: Expiry of patents exposes leading brands to generic competition eroding profits. Slow regulatory approvals along with compliance issues can disrupt supplies. Trade barriers and price controls affect availability and affordability of products. Dependence on biological raw materials exposes to supply chain risks. Key Takeaways The global Red Biotechnology Market Growth is expected to witness high growth. Regional analysis: North America currently dominates owing to strong biopharmaceutical industry and availability of advanced healthcare facilities. However, Asia Pacific is expected emerge as the fastest growing market due to expanding patient pool, increasing healthcare spending and improving research infrastructure in countries like China and India. Key players operating in the red biotechnology market are Kameda Seika Co., Ltd., Bourbon Corporation, Calbee, Inc., Glico Group, Ito En, Ltd., Yamazaki Baking Co., Ltd., Iwatsuka Confectionery Co., Ltd., Tanawachi Co., Ltd., Morinaga & Co., Ltd., Kobayashi Pharmaceutical Co., Ltd. Market leaders are focusing on new product launches, acquisitions and collaborations to consolidate their position. For instance, in 2022 Calbee acquired majority stake in Anthropic to strengthen AI capabilities and drive digital transformation. For more insights, read- https://www.pressreleasebulletin.com/red-biotechnology-market-trends-size-and-share-analysis/ Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are long-chain omega-3 fatty acids that play a vital role in brain function, heart health, joints, and reduce inflammation throughout the body. EPA and DHA are commonly found in fatty fish and fish oil supplements. With growing awareness about the health benefits of EPA and DHA, the demand for fish oil supplements and fortified/functional food and beverages is increasing rapidly. EPA and DHA find wide applications in dietary supplements, functional foods & beverages, pharmaceuticals, infant formula, and animal feed.
The global EPA and DHA omega-3 market is estimated to be valued at US$ 1853.38 Mn or Mn in 2023 and is expected to exhibit a CAGR of 23% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: Rising health awareness is the key driver propelling the growth of the EPA and DHA omega-3 market. Consumers are increasingly embracing healthy diets and lifestyle changes to prevent lifestyle diseases. Since EPA and DHA omega-3 fatty acids have demonstrated numerous health benefits such as reducing inflammation, lowering triglyceride levels, improving brain and eye health, and more, their demand is surging globally. Additionally, changing demographic trends towards the aged population who are more prone to chronic diseases will further aid the market expansion over the forecast period. However, fluctuations in fish catches and supply constraints associated with EPA and DHA extraction may hamper the market growth. SWOT Analysis Strength: The EPA and DHA market has high demand for food products with added nutritional value. Omega-3 fatty acids from fish oils are known to reduce the risk of heart disease and have other health benefits. EPA and DHA are vital for brain and eye development in infants as well. Supplements containing omega-3s are widely available to support cardiovascular and brain health in adults too. Weakness: Obtaining EPA and DHA through fish oil extraction can be an expensive process. Quality and sustainability concerns also exist regarding overfishing. Synthetic alternatives to fish oils require additional purification steps that drive up costs. Consumer confusion remains regarding the different types of omega-3 fatty acids and their health impacts. Opportunity: Growth of the dietary supplements industry presents an opportunity to market targeted EPA and DHA formulas. Demand is rising for plant-based and vegetarian DHA/EPA sources as more people adopt alternative diets. Innovation in algal and single-cell sources could address sustainability issues and reduce costs over time. Emerging science on additional benefits for conditions like depression also expands the potential market. Threats: Strict regulations on health claims and labeling accuracy apply to supplements. This may require additional studies and registration fees for new intended uses. Dependence on global fisheries resources poses risks from overfishing and environmental impacts on supply. Competition from substitutes like flaxseed oil and substitutes limits pricing power for producers and imposes pressure to innovate. Key Takeaways The global EPA And DHA Market Growth is expected to witness high growth over the forecast period driven by expanding applications in infant formula, supplements, and functional food and beverages. The global EPA and DHA omega-3 market is estimated to be valued at US$ 1853.38 Mn or Mn in 2023 and is expected to exhibit a CAGR of 23% over the forecast period 2023 to 2030. North America currently dominates the market owing to growing awareness about omega-3 benefits and preventive healthcare trends in the region. Europe is another major region for EPA and DHA while demand is rising fastest in Asia Pacific as more people adopt western diets and lifestyles. Key players operating in the EPA and DHA market include Broadcom Inc., Sicoya GMBH, GlobalFoundries Inc., Intel Corporation, Juniper Networks Inc., Cisco Systems Inc., IBM Corporation, and NeoPhotonics Corporation. These companies focus on fish oil extraction as well as developing algal and single-cell sources of DHA/EPA. Production innovation aims to address sustainability, costs, and future needs as omega-3 science advances and new clinical roles emerge. Players face challenges to scale efficiently while navigating strict regulations and competition from substitutes. Partnerships across the supply chain help secure resources and market share. For more insights, read- https://www.pressreleasebulletin.com/epa-and-dha-market-trends-size-and-share-analysis/ |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
February 2024
Categories
All
|